(Boursier.com) — Affluent Medical, a French medtech specializing in the international development and industrialization of innovative clinical-stage medical prostheses to treat urinary incontinence and cardiac mitral valve pathology, announces the initiation of security coverage by Kepler Cheuvreux. Affluent Medical now benefits from the follow-up of Kepler Cheuvreux with the publication of a study entitled “Kill three birds with one stone”.
This new rating completes the coverage of the stock and enriches the consensus of analysts alongside Swisslife and Invest Securities.
©2022 Boursier.com